Arcturus Therapeutics Holdings, Inc. (ARCT)
13.73
+0.86
(+6.68%)
USD |
NASDAQ |
Oct 09, 12:59
Arcturus Therapeutics Holdings Max Drawdown (5Y) : 95.23% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 95.23% |
| August 31, 2026 | 95.23% |
| July 31, 2026 | 95.23% |
| June 30, 2026 | 95.23% |
| May 31, 2026 | 95.23% |
| April 30, 2026 | 95.23% |
| March 31, 2026 | 95.23% |
| February 28, 2026 | 95.23% |
| January 31, 2026 | 95.23% |
| December 31, 2025 | 95.23% |
| November 30, 2025 | 95.23% |
| October 31, 2025 | 92.79% |
| September 30, 2025 | 92.79% |
| August 31, 2025 | 92.79% |
| July 31, 2025 | 92.79% |
| June 30, 2025 | 92.79% |
| May 31, 2025 | 92.79% |
| April 30, 2025 | 92.79% |
| March 31, 2025 | 91.44% |
| February 28, 2025 | 90.09% |
| January 31, 2025 | 90.09% |
| December 31, 2024 | 90.09% |
| November 30, 2024 | 90.09% |
| October 31, 2024 | 90.09% |
| September 30, 2024 | 90.09% |
| Date | Value |
|---|---|
| August 31, 2024 | 92.78% |
| July 31, 2024 | 94.21% |
| June 30, 2024 | 94.21% |
| May 31, 2024 | 96.20% |
| April 30, 2024 | 96.20% |
| March 31, 2024 | 96.20% |
| February 29, 2024 | 97.15% |
| January 31, 2024 | 97.24% |
| December 31, 2023 | 97.41% |
| November 30, 2023 | 97.65% |
| October 31, 2023 | 97.65% |
| September 30, 2023 | 97.65% |
| August 31, 2023 | 97.65% |
| July 31, 2023 | 97.65% |
| June 30, 2023 | 97.65% |
| May 31, 2023 | 97.65% |
| April 30, 2023 | 97.65% |
| March 31, 2023 | 97.65% |
| February 28, 2023 | 97.65% |
| January 31, 2023 | 97.65% |
| December 31, 2022 | 97.65% |
| November 30, 2022 | 97.65% |
| October 31, 2022 | 97.65% |
| September 30, 2022 | 97.65% |
| August 31, 2022 | 97.65% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Exelixis, Inc. | 53.09% |
| Ionis Pharmaceuticals, Inc. | 70.27% |
| United Therapeutics Corp. | 33.00% |
| PTC Therapeutics, Inc. | 73.78% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -50.76 |
| Beta (5Y) | 2.484 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 100.3% |
| Historical Sharpe Ratio (5Y) | -0.2583 |
| Historical Sortino (5Y) | -0.5767 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.36% |